Business
Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / July 18, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and BullFrog AI, Inc. (Nasdaq:BFRG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg ...
About this update from Bullfrog Ai Holdings, Inc.
[{"type":"text","content":"ORLANDO, FLORIDA / ACCESS Newswire / July 18, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and BullFrog AI, Inc. (Nasdaq:BFRG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, July 19, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.","length":386,"tagName":"p"},{"type":"text","content":"Access the interviews in their entirety at:","length":43,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"PCSA: https://www.redchip.com/assets/access/pcsa_access","length":55,"tagName":"p"}]},{"val":[{"type":"text","content":"BFRG: https://www.redchip.com/assets/access/bfrg_access.html","length":60,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":115,"olType":false},{"type":"text","content":"In an exclusive interview, George Ng, CEO of Processa Pharmaceuticals, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss how Processa is redefining oncology drug development by transforming existing chemotherapy agents into safer, more effective Next Generation Cancer (NGC) therapies. Ng highlights the company's lead asset, PCS6422 (NGC-Cap), now enrolling patients in a Phase 2 trial for metastatic breast cancer, and shares how Processa's Regulatory Science Approach positions it to generate superior tumor-targeting drugs with significantly reduced toxicity. He also discusses the company's recent $7M capital infusion, value-driving partnership with Intact Therapeutics for PCS12852, and its strategic pipeline realignment to prioritize assets with strong commercial and regulatory potential. With multiple near-term catalysts and a capital-efficient model, Processa offers a compelling microcap investment opportunity in the oncology space.","length":988,"tagName":"p"},{"type":"text","content":"Vin Singh, CEO of BullFrog AI, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss how BullFrog is redefining drug development through its enterprise-ready AI platform, BullFrog Data Networks™, powered by the proprietary bfLEAP™ engine. Singh explains how the company's multimodal, causal AI technology enables life sciences companies to uncover novel drug targets, optimize clinical trials, and repurpose existing therap...